Key terms

About ATR

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATR news

Apr 30 3:31am ET Analysts Offer Insights on Healthcare Companies: AptarGroup (ATR), Dexcom (DXCM) and Aldeyra Therapeutics (ALDX) by TipRanks Apr 29 9:33am ET AptarGroup upgraded to Outperform from Market Perform at William Blair by TipRanks Apr 29 6:49am ET AptarGroup price target raised to $170 from $150 at Baird by TipRanks Apr 29 6:19am ET AptarGroup price target raised to $163 from $160 at Wells Fargo by TipRanks Apr 26 5:48am ET AptarGroup’s Strong Q1 Performance and Robust Pharmaceutical Growth Justify Buy Rating by TipRanks Apr 25 5:02pm ET AptarGroup reports Q1 EPS $1.26, consensus $1.15 by TipRanks Mar 07 7:07am ET AptarGroup price target raised to $160 from $157 at Wells Fargo by TipRanks Feb 29 5:30am ET Analysts Offer Insights on Healthcare Companies: Arcellx Inc (ACLX), Sarepta Therapeutics (SRPT) and AptarGroup (ATR) by TipRanks Feb 13 7:20am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: AptarGroup (ATR), Halozyme (HALO) and Bausch Health Companies (BHC) by TipRanks Feb 12 6:09am ET AptarGroup price target raised to $157 from $152 at Wells Fargo by TipRanks Feb 12 5:55am ET AptarGroup: Strong Buy on Pharma Growth and Operational Efficiency by TipRanks Feb 11 11:55am ET AptarGroup’s Strong Performance and Growth Prospects Merit a Buy Rating by TipRanks Feb 10 1:02am ET Bad News for AptarGroup, Inc. Stock: This New Risk Has Been Added by TipRanks Feb 09 10:03am ET Aptar Digital Health enters enterprise agreement with Biogen by TipRanks Feb 08 5:07pm ET AptarGroup sees Q1 EPS $1.10-$1.18, consensus $1.12 by TipRanks Feb 08 5:06pm ET AptarGroup reports Q4 adjusted EPS $1.21, consensus $1.12 by TipRanks

No recent press releases are available for ATR

ATR Financials

1-year income & revenue

Key terms

ATR Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATR Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Warren Buffett (L), CEO of Berkshire Hathaway, and Vice Chairman Charlie Munger attend the 2019 annual shareholders meeting in Omaha, Nebraska, May 3, 2019.
Johannes Eisele/AFP/Getty Images
Warren Buffett holds first Berkshire Hathaway meeting without Charlie Munger
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stocks close higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again